Glioma - Therapy
Research News and Information

Saturday, November 21, 2009

6-year-old girl with hydrocephalus.

29 Sep 2009 With rare exceptions, pediatric tectal gliomas have been generally reported as low-grade tumors with relatively good prognosis. The patients are usually treated conservatively to manage the signs and symptoms of obstructive hydrocephalus. We report ... Read more...

Dendritic cell therapy of high-grade gliomas.

29 Sep 2009 The prognosis of patients with malignant glioma is poor in spite of multimodal treatment approaches consisting of neurosurgery, radiochemotherapy and maintenance chemotherapy. Among innovative treatment strategies like targeted therapy, ... Read more...

Immunotherapy of diffuse gliomas: biological background, current status and future developments.

29 Sep 2009 Despite aggressive multimodal treatment approaches, the prognosis for patients with diffuse gliomas remains disappointing. Glioma cells often extensively infiltrate in the surrounding brain parenchyma, a phenomenon that helps them to escape surgical ... Read more...

Latest indexed articles for 'Glioma - Therapy'

These are the very latest articles for this heading:

• 6-year-old girl with hydrocephalus. 29 Sep 2009
• Dendritic cell therapy of high-grade gliomas. 29 Sep 2009
• Immunotherapy of diffuse gliomas: biological background, current status and future developments. 29 Sep 2009
• Immunotherapy of diffuse gliomas: helping the brain fight back! 29 Sep 2009
• Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. 30 Aug 2009
• Survival and functional outcome of childhood spinal cord low-grade gliomas. Clinical article. 30 Aug 2009
• Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic. 30 Aug 2009
• Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction. 30 Jul 2009
• IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. 30 Jul 2009
• Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. 25 Jul 2009
• Repeated molecular testing in gliomas: a retrospective study of 53 cases. 29 Jun 2009
• [Oncolytic virus therapy for malignant brain tumors] 29 Jun 2009
• [New roles of glutamate receptors in glias and gliomas] 29 Jun 2009
• Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity. 29 Jun 2009
• Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function. 29 Jun 2009
• Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas. 29 Jun 2009
• Pediatric brain tumors: current treatment strategies and future therapeutic approaches. 29 Jun 2009
• Oncolytic viral therapy of malignant glioma. 29 Jun 2009
• Gene- and viral-based therapies for brain tumors. 29 Jun 2009
• Toward effective immunotherapy for the treatment of malignant brain tumors. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Glioma'

Definition: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Descriptor UI: D005910

Alternative terms: Glioma; Gliomas; Glial Cell Tumors; Glial Cell Tumor; Tumor, Glial Cell; Tumors, Glial Cell; Mixed Glioma; Glioma, Mixed; Gliomas, Mixed; Mixed Gliomas; Malignant Glioma; Glioma, Malignant; Gliomas, Malignant; Malignant Gliomas;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.557.465.625.600.380; C04.557.470.670.380; C04.557.580.625.600.380;

Technical Notes: coord IM with precoord CNS/neopl term + site (IM); GLIOMA, SUBEPENDYMAL is available; for sarcomatous GLIOMA use GLIOSARCOMA; for GLIOMA, RETINAL see RETINOBLASTOMA